Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice
about
Prevention of oncogenic viral infections in mice with CGP 11637, a synthetic muramyl dipeptide analog.Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.Uveitis induction in the rabbit by muramyl dipeptidesSynergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis.Activation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives.Harnessing the beneficial heterologous effects of vaccination.Trained immunity: A program of innate immune memory in health and disease.Synergistic effects of romurtide and cefmenoxime against experimental Klebsiella pneumonia in mice.Anti-infectious activity of liposomal muramyl dipeptides in immunodeficient CBA/N mice.Stimulation of complement production in mice by N alpha-(N-acetylmuramyl-L-alanyl-D-isoglutamine)-N epsilon-stearoyl-L-lysine.Stimulatory effect of N-acetyl Muramyl dipeptide in vivo: proliferation of bone marrow progenitor cells in miceStimulation of resistance of immunocompromised mice by a muramyl dipeptide analog.Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog.Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections.
P2860
Q35572178-6D382044-80E9-4BC1-A590-AE40209DCDA7Q36431289-DF33EAB1-2C95-424D-AA7E-8AF9CDF04BE5Q36433792-6A149E1F-DDAF-4E56-B37A-B638D8921322Q37028172-2772CDB5-2C52-45E6-BA8C-40CE07578B27Q37035564-2A0D741F-16F0-4F15-A460-EC323C646FF1Q37036204-5B6EFF48-D9E6-496C-BEEE-3C94A9ECF352Q37061098-5054D6F3-D73F-4ECD-9D8F-99E07063D1C6Q38814347-04FD8D93-01C6-461E-B45E-1D79A679C595Q39870991-FFA63E53-9A02-4FE9-A4E4-37017649B248Q40163385-DC6B9E2D-8B61-47F6-B1F7-02D564985D25Q40182443-C4FBF2E8-7BA5-4A8D-B943-FE18C32BDA16Q40598071-5FBB0006-2ABE-4678-B2CC-744BB4CF2600Q40598634-D8DB8CDC-49ED-4EA6-99BF-790B6D119995Q40599272-263515FB-CE9B-4C81-9D1D-F8DB9355A961Q42719351-59746843-E26B-4175-82E7-7BCFA24E11D6
P2860
Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
Effects of muramyl dipeptide t ...... with Toxoplasma gondii in mice
@ast
Effects of muramyl dipeptide t ...... with Toxoplasma gondii in mice
@en
type
label
Effects of muramyl dipeptide t ...... with Toxoplasma gondii in mice
@ast
Effects of muramyl dipeptide t ...... with Toxoplasma gondii in mice
@en
prefLabel
Effects of muramyl dipeptide t ...... with Toxoplasma gondii in mice
@ast
Effects of muramyl dipeptide t ...... with Toxoplasma gondii in mice
@en
P2093
P2860
P1476
Effects of muramyl dipeptide t ...... with Toxoplasma gondii in mice
@en
P2093
J L Krahenbuhl
J S Remington
R W Ferraresi
S D Sharma
P2860
P304
P407
P577
1981-02-01T00:00:00Z